Intranasal COVID-19 Vaccine May Be More Effective Than Injected Vaccines

There are more than 150 experimental COVID-19 vaccines under development around the world, all of which are being designed for intramuscular injection.1 Some researchers are investigating whether the conventional intramuscular injection route is less effective when using vaccines to prevent microbial infections that invade the respiratory airway like SARS-CoV-2.2 Avery August, PhD, an immunologist at […]
Pfizer/BioNTech’s COVID-19 Vaccine Causes Adverse Reactions in Over Half of Clinical Trial Volunteers

In clinical trials of the experimental messenger RNA (ribonucleic acid) COVID-19 vaccine (BNT162b1), which is being developed by Pfizer, Inc. of New York and BioNTech SE of Mainz, Germany, adverse reactions have occurred in more than 50 percent of the adult participants. The Phase 1/2 human trials of BNT162b1 vaccine, which were conducted May-June 2020, […]
U.S. Troops Will Be Among the First to Get COVID-19 Vaccine

Senior White House officials reported that United States service members would be among the first Americans to receive a COVID-19 vaccine after it has been licensed. Officials said the groups likely to receive the vaccine first include the most vulnerable people such as the elderly, patients with underlying health conditions, employees in essential businesses and […]
Infant Boy in India Dies Hours After Getting Oral Polio Vaccine

A seven-month-old infant boy died on July 7, 2020 within hours of receiving the live attenuated oral polio vaccine (OPV) in Palghar, India. The baby was given one dose of the OPV drops in the evening and was found dead the following morning by his parents.1 2 3 According to a news report, government welfare […]
81 Percent of Clinical Trial Volunteers Suffer Reactions to CanSino Biologics’ COVID-19 Vaccine That Uses HEK293 Human Fetal Cell Lines

An experimental vaccine for COVID-19 is being developed by CanSino Biologics, Inc. of Tianjin, China, in partnership with China’s Academy of Military Medical Sciences’ Institute of Biotechnology. A Phase 1 human clinical trial of the COVID-19 vaccine (adenovirus type-5 Ad5-nCoV) has been completed in China involving 108 healthy adults, ranging in age from 45–60 years […]
Israeli Woman Treated with COVID-19 “Passive Vaccine”

Hadassah Medical Center in partnership with the Israeli biotechnology company Kamada Ltd. in Jerusalem, Israel treated its first COVID-19 patient with what it described as a “passive vaccine.”1 Reportedly, a young female suffering from several underlying medical conditions, who had been hospitalized for several weeks and intubated, was passively vaccinated by injecting antibodies from a […]